Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Vasc Res ; 53(1-2): 27-38, 2016.
Article in English | MEDLINE | ID: mdl-27372431

ABSTRACT

BACKGROUND: Our previous study suggested that heart-type fatty acid-binding protein (HFABP) levels were greatly elevated in the conditioned medium of explant culture of in-stent restenosis (ISR) tissue from diabetic minipigs compared with those of non-ISR tissue. We here verified this result in animal tissues and investigated the impact of HFABP overexpression in human aortic smooth muscle cells (hASMCs). METHODS AND RESULTS: In Western blot and real-time RT-PCR, HFABP protein and mRNA levels were significantly higher in ISR than in non-ISR tissues from minipigs, and higher in the ISR tissue from diabetic minipigs than that from nondiabetic minipigs. The mRNA microarray and cellular effects of hASMC retroviral overexpression of HFABP and vector was analyzed. Compared with vector, HFABP transduction activates multiple signaling pathways (e.g. adipokine, TGF-ß, Toll-like receptor, Wnt, Hedgehog, ErbB and Notch) and promotes inflammation, growth and migration in hASMCs whereas the knockdown of HFABP by small hairpin RNA attenuates these effects. CONCLUSION: HFABP expression is significantly higher in ISR tissue than in non-ISR tissue from diabetic and nondiabetic minipigs. Overexpression of HFABP induces multiple pathway-related promotion of inflammation, growth and migration in vascular SMCs, suggesting a potential role in coronary artery ISR.


Subject(s)
Cell Movement , Cell Proliferation , Coronary Restenosis/metabolism , Diabetes Mellitus, Experimental/complications , Fatty Acid-Binding Proteins/metabolism , Inflammation/metabolism , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Percutaneous Coronary Intervention/instrumentation , Stents , Animals , Cells, Cultured , Coronary Restenosis/etiology , Coronary Restenosis/genetics , Coronary Restenosis/pathology , Coronary Vessels/metabolism , Coronary Vessels/pathology , Fatty Acid Binding Protein 3 , Fatty Acid-Binding Proteins/genetics , Gene Regulatory Networks , Humans , Inflammation/etiology , Inflammation/genetics , Inflammation/pathology , Inflammation Mediators/metabolism , Male , Muscle, Smooth, Vascular/pathology , Myocytes, Smooth Muscle/pathology , Percutaneous Coronary Intervention/adverse effects , RNA Interference , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Swine , Swine, Miniature , Time Factors , Tissue Culture Techniques , Transfection , Up-Regulation
2.
Arterioscler Thromb Vasc Biol ; 33(3): 572-80, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23372061

ABSTRACT

OBJECTIVE: We aimed to uncover the protein changes of coronary artery in-stent restenosis (ISR) tissue in minipigs with and without streptozotocin-induced diabetes mellitus by quantitative 2-dimensional fluorescence in-gel electrophoresis (2D-DIGE), and to investigate the influences of crucial proteins identified, particularly adipocyte fatty acid binding protein (AFABP), in human arterial smooth muscle cells. METHODS AND RESULTS: Sirolimus-eluting stents were implanted in the coronary arteries of 15 diabetic and 26 nondiabetic minipigs, and angiography was repeated after 6 months. The intima tissue of significant ISR and non-ISR segments in both diabetic and nondiabetic minipigs was analyzed by 2D-DIGE and MALDI-TOF/TOF mass spectrometry. AFABP level was significantly increased in ISR tissue than in non-ISR tissue in both diabetic and nondiabetic minipigs, with level being higher in diabetic ISR than in nondiabetic ISR tissue. In human arterial smooth muscle cells, overexpression of AFABP significantly altered phenotype and promoted growth and migration, with effects more prominent in high-glucose than in low-glucose medium, whereas AFABP knockdown inhibited these effects. AFABP overexpression increased reactive oxygen species production by upregulating the expression of NADPH oxidase subunits Nox1, Nox4, and P22 through multiple pathways, with elevation of downstream gene cyclin D1, matrix metalloproteinase-2, and monocyte chemoattractant protein-1. However, AFABP-induced effects were inhibited by diphenyleneiodonium, pathway inhibitors, and small interfering RNA. In addition, the supernatant from AFABP-expressing human arterial smooth muscle cells and recombinant AFABP also promoted cellular growth and migration. CONCLUSIONS: This study has demonstrated that AFABP is significantly increased in coronary artery ISR segments of both diabetic and nondiabetic minipigs. Increased AFABP expression and secretory AFABP of human arterial smooth muscle cells promote growth and migration via reactive oxygen species-mediated activation.


Subject(s)
Cell Movement , Cell Proliferation , Coronary Restenosis/metabolism , Electrophoresis, Gel, Two-Dimensional , Fatty Acid-Binding Proteins/metabolism , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Reactive Oxygen Species/metabolism , Animals , Cardiovascular Agents/administration & dosage , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Coronary Restenosis/etiology , Coronary Restenosis/genetics , Coronary Restenosis/pathology , Coronary Vessels/metabolism , Coronary Vessels/pathology , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Drug-Eluting Stents , Enzyme Inhibitors/pharmacology , Fatty Acid-Binding Proteins/genetics , Fluorescence , Glucose/metabolism , Humans , Male , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/pathology , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/pathology , NADPH Oxidases/genetics , NADPH Oxidases/metabolism , NF-kappa B/metabolism , Neointima , Oxidative Stress , Percutaneous Coronary Intervention/adverse effects , Percutaneous Coronary Intervention/instrumentation , Phenotype , RNA Interference , RNA, Messenger/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , Sirolimus/administration & dosage , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Swine , Swine, Miniature , Time Factors , Transcription Factor AP-1/metabolism , Transfection , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...